Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
帕博利珠单抗、放疗和免疫调节五药鸡尾酒疗法治疗持续性、复发性或转移性宫颈癌或子宫内膜癌的治疗效果:II 期 PRIMMO 研究结果
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-022-03253-x
Emiel A De Jaeghere, Sandra Tuyaerts, An M T Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens, Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, Peter A van Dam, Sandrine Aspeslagh, Alex De Caluwé, Eline Naert, Diether Lambrechts, An Hendrix, Olivier De Wever, Koen K Van